Kees Bisschop
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Inflammatory Biomarkers in Disease Prognosis
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Surgical Treatments 2
- Cutaneous Melanoma Detection and Management 1
- CAR-T cell therapy research 1
- Co-authors
- Geke A.P. Hospers (5 shared papers)Ellen C. de Heer (1 shared paper)Mathilde Jalving (1 shared paper)Adrienne H. Brouwers (1 shared paper)Jan Willem B. de Groot (2 shared papers)Ellen Kapiteijn (1 shared paper)Arjen Joosse (1 shared paper)Christian U. Blank (1 shared paper)
- Journals
- Annals of Surgical Oncology (2 papers)Critical Reviews in Oncology/Hematology (1 paper)Acta Oncologica (1 paper)British Journal of Dermatology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- NetherlandsGermanyItaly
In The Last Decade
Kees Bisschop
6 papers receiving 636 citations
Kees Bisschop's Hit Papers
Peers
Comparison fields: 5 of 47
- Oncology 420
- Immunology 206
- Ophthalmology 40
- Cancer Research 54
- Pulmonary and Respiratory Medicine 78
Countries citing papers authored by Kees Bisschop
This map shows the geographic impact of Kees Bisschop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kees Bisschop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kees Bisschop more than expected).
Fields of papers citing papers by Kees Bisschop
This network shows the impact of papers produced by Kees Bisschop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kees Bisschop. The network helps show where Kees Bisschop may publish in the future.
Co-authors
The 25 scholars most cited alongside Kees Bisschop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab Hit paper breakdown → | 2016 | 497 |
| 2 | 2016 | 43 | |
| 3 | 2017 | 42 | |
| 4 | 2020 | 39 | |
| 5 | 2016 | 14 | |
| 6 | 2014 | 6 |
About Kees Bisschop
Kees Bisschop is a scholar working on Oncology, Ophthalmology, Dermatology, Neurology and Immunology, having authored 6 papers that have together received 641 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Colorectal Cancer Surgical Treatments (2 papers), Cutaneous Melanoma Detection and Management (1 paper), Veterinary Oncology Research (1 paper), CAR-T cell therapy research (1 paper), Facial Rejuvenation and Surgery Techniques (1 paper), Immunotherapy and Immune Responses (1 paper) and Autoimmune and Inflammatory Disorders (1 paper). The work is most often cited by research in Oncology (420 citations), Immunology (206 citations), Ophthalmology (40 citations), Cancer Research (54 citations) and Pulmonary and Respiratory Medicine (78 citations). Kees Bisschop has collaborated with scholars based in Netherlands, Germany and Italy. Frequent co-authors include Geke A.P. Hospers, Ellen C. de Heer, Mathilde Jalving, Adrienne H. Brouwers, Jan Willem B. de Groot, Ellen Kapiteijn, Arjen Joosse, Christian U. Blank, Rutger H.T. Koornstra and Monique K. van der Kooij. Their work appears in journals such as Annals of Surgical Oncology, Critical Reviews in Oncology/Hematology, Acta Oncologica, British Journal of Dermatology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.